Our Story

An American Manufacturer with a National Purpose

Oxford Pharmaceuticals was founded with a simple but powerful idea — that the medicines Americans depend on should be made in America.

From our headquarters and manufacturing facility in Birmingham, Alabama, we produce essential generic medicines under full FDA and cGMP compliance. Every batch we produce strengthens the nation’s healthcare security and restores confidence in the safety, quality, and reliability of our drug supply.

Oxford isn’t just a pharmaceutical company — it’s part of a movement to rebuild America’s medical manufacturing base and end our reliance on foreign adversaries for essential medicines.

The Problem We’re Solving

Today, up to 80% of the United States’ active pharmaceutical ingredients (APIs) come from foreign suppliers — primarily China and India. That dependency has created critical vulnerabilities:

When foreign factories shut down or export bans occur, American hospitals and pharmacies face shortages within weeks.

Neither can our country.

For decades, the U.S. has steadily outsourced pharmaceutical production overseas.

Today, up to 80% of our active pharmaceutical ingredients (APIs) come from foreign suppliers — primarily China and India. That dependency has created critical vulnerabilities:

When foreign factories shut down or export bans occur, American hospitals and pharmacies face shortages within weeks. Patients waiting for life-sustaining drugs like insulin or chemotherapy agents can’t afford those risks. Neither can the country.

Our Response

Build It Here

Oxford was built as part of the solution.

Our Alabama facility was designed to meet the highest standards of quality and security — not only to compete globally but to lead by example. Every process, from blending to coating, operates under strict environmental and validation controls. Our in-house quality team conducts continuous testing and traceability across the full production cycle.

By manufacturing domestically, we cut months out of the supply chain, eliminate exposure to foreign instability, and create American jobs. That’s the Oxford advantage — shorter lead times, higher accountability, and complete control over quality.

Beyond Compliance

A Culture of Trust

Compliance is where quality begins, not where it ends.

At Oxford, every technician, engineer, and operator is trained not just in procedures but in purpose — understanding that behind every tablet is a patient depending on us to do it right. We invest heavily in continuous improvement, staff training, and process innovation, ensuring that our facility operates at the highest global standards every single day.

Our people are our strength. Many of our team members came from legacy pharmaceutical plants across the region, bringing decades of hands-on experience. Together, we’re not just making medicine — we’re rebuilding an industry.

Leadership in America’s Pharmaceutical Resurgence

Oxford stands at the center of a national effort to reshore essential medicine manufacturing.

We collaborate with industry leaders, government agencies, and healthcare partners to increase U.S. drug independence. With support from logistics and distribution partners like iRemedy Healthcare, our products reach hospitals and healthcare systems across the nation quickly and securely.

We’re also aligned with federal priorities to strengthen the Strategic National Stockpile and ensure long-term supply stability through domestic capacity. Oxford represents what’s possible when American innovation, industry, and integrity work together.

Our Commitment

Oxford Pharmaceuticals is proud to lead this charge — proving that the future of medicine can, and should, be Made in America.